LEADER 03204nam  22007813u 450 
001 9910708380103321
005 20230912133347.0
010   $a1-280-75126-6
010   $a9786610751266
010   $a1-84692-578-9
035   $a(CKB)1000000000550602
035   $a(EBL)362686
035   $a(OCoLC)476193565
035   $a(SSID)ssj0000828652
035   $a(PQKBManifestationID)11448034
035   $a(PQKBTitleCode)TC0000828652
035   $a(PQKBWorkID)10833943
035   $a(PQKB)10627080
035   $a(OCoLC)428086015
035   $a(MiAaPQ)60386
035   $a(EXLCZ)991000000000550602
100   $a20130418d2007||||  u||            |
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aAsthma$b[electronic resource] $eCurrent Treatments
210   $aOxford $cAtlas Medical Publishing Ltd$d2007
210  1$a[Rockville, Md.] :$cFDA, Office of Women's Health,$d2007.
215   $a1 online resource (200 p.)
225 1 $aTherapeutic Strategies
300   $aDescription based upon print version of record.
311   $a1-84692-015-9 
327   $aContents; Editors and Contributors; Preface; Section I: First line anti-inflammatory and bronchodilator drugs; Section II: Novel approaches to bronchodilation; Section III: Immunomodulation; Section IV: Subphenotype centred therapy; Abbreviations; Index
330   $aAs the incidence of asthma in the adult population continues to increase, and the age of onset in children to decrease, this condition remains a primary concern not only for specialists in respiratory medicine, but also for physicians in many other fields, when dealing with the asthmatic patient. The range of therapeutic agents now available, and the diversity of targets on which they act, presents the doctor with a variety of options for managing the condition. In this volume leading international authorities explain the mechanisms of action of the drugs currently in use, and their clinical a
410  0$aTherapeutic Strategies
606   $aAnti-asthmatic agents
606   $aAsthma -- Chemotherapy
606   $aAsthma -- Diagnosis
606   $aAsthma -- Diet therapy
606   $aAsthma -- Exercise therapy
606   $aAsthma -- Treatment
606   $aAsthma in children -- Prevention
606   $aAsthma
606   $aLungs -- Diseases, Obstructive -- Chemotherapy
615  4$aAnti-asthmatic agents.
615  4$aAsthma -- Chemotherapy.
615  4$aAsthma -- Diagnosis.
615  4$aAsthma -- Diet therapy.
615  4$aAsthma -- Exercise therapy.
615  4$aAsthma -- Treatment.
615  4$aAsthma in children -- Prevention.
615  4$aAsthma.
615  4$aLungs -- Diseases, Obstructive -- Chemotherapy.
676   $a616.2
676   $a616.2/3061
676   $a616.2/38061
700   $aPolosa$b Riccardo$01008374
701   $aHolgate$b S. T$0878514
712 02$aUnited States.$bFood and Drug Administration.$bOffice of Women's Health,
801  0$bAU-PeEL
801  1$bAU-PeEL
801  2$bAU-PeEL
906   $aBOOK
912   $a9910708380103321
996   $aAsthma$92325676
997   $aUNINA